Growth Metrics

Cigna (CI) EBIT Margin (2017 - 2026)

Cigna recorded quarterly EBIT Margin of 2.06% in Q1 2026, down 91.85% quarter-over-quarter from 25.25% in Q4 2025, and up 170.0% year-over-year from 0.76% in Q1 2025.

Cigna's EBIT Margin history runs 10 years deep, the most recent figure standing at 2.06% for Q1 2026.

  • In Q1 2026, EBIT Margin rose 170.0% year-over-year to 2.06%; the TTM figure through Mar 2026 stood at 8.08% (up 656.0% YoY), while the FY2025 annual figure was 22.85%, up 1904.0% from the prior year.
  • EBIT Margin came in at 2.06% for Q1 2026 at Cigna, down from 25.25% in the prior quarter.
  • In the past five years, EBIT Margin ranged from a high of 68.55% in Q4 2023 to a low of 1.84% in Q4 2022.
  • A 5-year average of 10.29% and a median of 2.52% in 2023 frame the typical range for EBIT Margin.
  • Across the five-year window, EBIT Margin soared 7039 bps in 2023 and tumbled 6752 bps in 2024, its largest moves.
  • Cigna's EBIT Margin stood at 1.84% in 2022, then jumped by 3817 bps to 68.55% in 2023, then slumped by 99 bps to 1.02% in 2024, then surged by 2370 bps to 25.25% in 2025, then sank by 92 bps to 2.06% in 2026.
  • According to Business Quant data, EBIT Margin over the past three periods registered 2.06%, 25.25%, and 2.57% for Q1 2026, Q4 2025, and Q3 2025 respectively.

Historic Data

Download Data 🔒
DateValue
Mar 31, 2026 2.06%
Dec 31, 2025 25.25%
Sep 30, 2025 2.57%
Jun 30, 2025 2.58%
Mar 31, 2025 0.36%
Dec 31, 2024 1.02%
Sep 30, 2024 22.53%
Jun 30, 2024 0.53%
Mar 31, 2024 19.44%
Dec 31, 2023 68.55%
Sep 30, 2023 2.92%
Jun 30, 2023 2.52%
Mar 31, 2023 2.51%
Dec 31, 2022 -1.84%
Sep 30, 2022 2.13%
Jun 30, 2022 0.71%
Mar 31, 2022 21.13%
Dec 31, 2021 -10.62%
Sep 30, 2021 1.06%
Jun 30, 2021 3.00%
Mar 31, 2021 3.83%
Dec 31, 2020 3.47%
Sep 30, 2020 0.73%
Jun 30, 2020 0.57%
Mar 31, 2020 5.36%
Dec 31, 2019 18.41%
Sep 30, 2019 21.37%
Jun 30, 2019 3.47%
Mar 31, 2019 5.88%
Dec 31, 2018 3.10%
Sep 30, 2018 9.88%
Jun 30, 2018 10.11%
Mar 31, 2018 11.46%
Dec 31, 2017 7.13%